Why the study?
How do the ancillary properties of beta adrenoceptor antagonists (beta 1 selectivity, partial agonism, membrane-stabilizing action) influence their efficacy and tolerability in the management of angina pectoris?
Population
Patients with angina pectoris
Comparison
Beta adrenoceptor antagonists with ancillary… vs Beta adrenoceptor antagonists without these…
Design
Review
Authors
Loading...
Ancillary properties may guide beta-blocker selection in angina with comorbidities; leaves open need for modern head-to-head trials.
How do the ancillary properties of beta adrenoceptor antagonists (beta 1 selectivity, partial agonism, membrane-stabilizing action) influence their efficacy and tolerability in the management of angina pectoris?
The ancillary properties of beta-blockers, such as cardioselectivity and partial agonism, provide specific clinical advantages and tolerability profiles in the management of angina pectoris, though some uncertainties remain.
J. D. Fitzgerald (1985) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: